Medical clinic and research facility Olympus Stem Cells Pty Ltd, based in Sydney Olympic Park, NSW, Australia, are pleased to announce the provision of medical services relating to the use of Stem Cells for dry eyes and painful eyes. More details can be obtained at http://www.olympusstemcells.com.au.
The Medical Director of Olympus Stem Cells, Associate Professor Russell Vickers, has published extensively on the use of stem cells in neuropathic facial pain. He is now conducting clinical treatment of patients with dry eyes from age related dry eyes, Sjogrens disease or dry eye syndrome post LASIK surgery.
Associate Professor Vickers says: "Stem Cell Therapy is a highly effective means of alleviating pain and discomfort for people suffering a variety of conditions ranging from osteoarthritis to ligament and cartilage damage. We are proud to be one of Sydney's best Stem Cell Therapy providers, with a proven track record of providing safe, effective treatment and expert care for our patients. Olympus has a strong focus on research and development and is working hard to constantly further the advancement of stem cell techniques around the world. Our research has been published internationally in peer-reviewed medical and science journals, plus our laboratory boasts some of the best state-of-the-art biotechnology equipment in Australia."
Stem Cells are extracted from abdominal wall fat following a mini liposuction procedure. The procedure is conducted under local anaesthesia and stem cells are extracted following aspiration of 20-40cc's of fat. The cells and stromal vascular fraction are then injected into the lacrimal and tear producing glands around the orbit and eye.
Olympus Stem Cells Pty Ltd are the only company undertaking this ground breaking treatment in Australia and the Asia-Pacific region. The surgery is day stay only. More information on the clinic and the work that they do can be obtained at http://www.olympushealthgroup.com.au.
Associate Professor Vickers' recent research publications pertaining to stem cells and facial pain are extensive. These publications include Human Brain Mapping, the Australian Endodontic Journal, Hair Therapy and Transplantation, The Journal of Neuroscience, Diagnosing Dental and Orofacial Pain, the Journal of the Australian Society of Cosmetic Chemists, Medicine Today (the journal of the Royal Australian College of General Practitioners), the Open Journal of Dentistry and Oral Medicine, and the Journal of Pain Research. More information on Associate Professor Vickers' work can be obtained at http://www.clinicalstemcells.com.
Olympus Stem Cells Pty Ltd are a clinical research and development biotech company engaged in stem cell therapy in Sydney, Australia.
Olympus Stem Cell Centre,
Sydney Olympic Park,
5 Australia Avenue,
Sydney Olympic Park,
NSW, Australia.
April 12, 2018 – Olympus Stem Cells Pty Ltd Australia Demonstrating Superior Stem Cell Numbers and Viability in Treatment for Neuropathy
April 12, 2018 – Stem Cells For Hair Regeneration
April 04, 2018 – Dry Mouth from Sjogren’s Syndrome or Head and Neck Radiation: Olympus Stem Cells Advise Technical Considerations in Surgery
April 03, 2018 – Dry Eyes and Stem Cells: Olympus Stem Cells Advise Technical Considerations in Surgery
April 02, 2018 – Olympus Stem Cells Using Zinc Thymulin, Micro-Fat Grafting and Stem Cells for Baldness
April 02, 2018 – Olympus Stem Cells Using Palmitoylethanolamide (PEA) and Stem Cells for Control of Disabling Facial Neuropathic Pain
March 26, 2018 – Olympus Stem Cells Pty Ltd Highlight Relationship Between Goblet Cells, Neuropathic Pain and Post LASIK Dry Eye Syndrome
March 26, 2018 – Olympus Stem Cells Pty Ltd Highlight Relationship Between Neural Crest Cells and Neuropathic Pain in Empty Nose Syndrome